Local Institution - 001-544B — Omaha, Nebraska

Local Institution - 001-544B is a clinical research site located in Omaha, Nebraska, United States 68105-1850.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 001-544B has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease.

Sponsors: Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 001-544B?

Local Institution - 001-544B has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 001-544B conducted?

Local Institution - 001-544B has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease.

Is Local Institution - 001-544B accredited by Crixeo Health?

Local Institution - 001-544B has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 001-544B?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.